Plenty of fish [oil] in the sea, have we REDUCEd-IT to one?

Check out this episode as Dr. Dave Dixon talks about REDUCE-IT and REDUCE-IT USA. 

0:00-0:41: Intro
0:42-1:26: Introduction of Dr. Dave Dixon
1:27-5:10: Introduction of REDUCE-IT and REDUCE-IT USA
5:11-6:30: Dave’s Initial Thoughts
6:31-8:21: Why not OTC fish oil or omega-3 fatty acid prescriptions?
8:22-9:54: Were these patients well managed at baseline?
9:55-11:15: Who should we avoid icosapent ethyl in?
11:16-12:19: Labeling Changes
12:20-14:16: Final Thoughts
14:17-15:01: Closing

REDUCE-IT: Bhatt DL, Steg G, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med2019;380:11-22.
Bhatt DL, Miller M, BrintonE, et al. REDUCE-IT USA: Results from the 3,146 Patients Randomized in the United States. Circulation 2019; doi: 10.1161/CIRCULATIONAHA.119.044440. 
FDA New Release: 

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: